TARO - Taro Pharmaceutical Non-GAAP EPS of $0.40 beats by $0.09 revenue of $158.9M beats by $9.87M July, 27 2023 05:45 AM Taro Pharmaceutical Industries Ltd. 2023-07-27 05:45:35 ET Taro Pharmaceutical press release ( NYSE: TARO ): Q2 Non-GAAP EPS of $0.40 beats by $0.09 . Revenue of $158.9M (+1.4% Y/Y) beats by $9.87M . For further details see: Taro Pharmaceutical Non-GAAP EPS of $0.40 beats by $0.09, revenue of $158.9M beats by $9.87M